JTE-607 dihydrochloride
- Product Name
- JTE-607 dihydrochloride
- CAS No.
- 188791-09-5
- Chemical Name
- JTE-607 dihydrochloride
- Synonyms
- JTE-607 HCl;JTE-607, 10 mM in DMSO;JTE-607 dihydrochloride;N-[3,5-Dichloro-2-hydroxy-4-[2-(4-methyl-1-piperazinyl)ethoxy]benzoyl]-L-phenylalanine ethyl ester dihydrochloride;(S)-Ethyl 2-(3,5-dichloro-2-hydroxy-4-(2-(4-methylpiperazin-1-yl)ethoxy)benzamido)-3-phenylpropanoate dihydrochloride;IL-6,IL-1β,endotoxin,CPSF3,Anti-inflammatory,TNF-α,JTE-607,JTE 607,Interleukin Related,IL-8,Cytokine,Inhibitor,Inflammatory,JTE607,Immunosuppression,IL-10,inhibit
- CBNumber
- CB04718628
- Molecular Formula
- C25H32Cl3N3O5
- Formula Weight
- 560.9
- MOL File
- 188791-09-5.mol
JTE-607 dihydrochloride Property
- storage temp.
- -20° (des.)
- solubility
- Soluble in DMSO (up to 25 mg/ml).
- form
- solid
- color
- Off-white to pale yellow
- Water Solubility
- H2O: 2mg/mL, clear
- Stability:
- Stable for 1 year as supplied. Solutions in DMSO may be stored at -20° for up to 1 month.
- InChIKey
- JUJAUEQJEWIWCQ-FJSYBICCSA-N
- SMILES
- Clc1c(c(cc(c1O)C(=O)N[C@@H](Cc3ccccc3)C(=O)OCC)Cl)OCCN2CCN(CC2)C.Cl.Cl
Safety
- WGK Germany
- WGK 3
- Storage Class
- 11 - Combustible Solids
Hazard and Precautionary Statements (GHS)
- Symbol(GHS)
-
- Signal word
- Warning
- Hazard statements
-
H302Harmful if swallowed
H315Causes skin irritation
H319Causes serious eye irritation
H335May cause respiratory irritation
- Precautionary statements
-
P261Avoid breathing dust/fume/gas/mist/vapours/spray.
P280Wear protective gloves/protective clothing/eye protection/face protection.
P301+P312IF SWALLOWED: call a POISON CENTER or doctor/physician IF you feel unwell.
P302+P352IF ON SKIN: wash with plenty of soap and water.
P305+P351+P338IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continuerinsing.
N-Bromosuccinimide Price
- Product number
- SML2833
- Product name
- JTE-607
- Purity
- ≥98% (HPLC)
- Packaging
- 5 mg
- Price
- $127.3
- Updated
- 2025/07/31
- Product number
- SML2833
- Product name
- JTE-607
- Purity
- ≥98% (HPLC)
- Packaging
- 25 mg
- Price
- $538
- Updated
- 2025/07/31
- Product number
- 5185
- Product name
- JTE607dihydrochloride
- Purity
- ≥98%(HPLC)
- Packaging
- 10
- Price
- $265
- Updated
- 2021/12/16
- Product number
- 5185
- Product name
- JTE607dihydrochloride
- Purity
- ≥98%(HPLC)
- Packaging
- 50
- Price
- $1113
- Updated
- 2021/12/16
- Product number
- J211965
- Product name
- JTE607Dihydrochloride
- Packaging
- 10mg
- Price
- $235
- Updated
- 2021/12/16
JTE-607 dihydrochloride Chemical Properties,Usage,Production
Description
JTE-607 (188791-09-5) inhibits inflammatory cytokine production in human peripheral blood mononuclear cells (PBMC’s) without causing immunosuppression: IC50’s = 11 nM (TNF-α), 5.9 nM (IL-1β), 8.8 nM (IL-6), 7.3 nM (IL-8), and 9.1 nM (IL-10).1?It displayed efficacy in a mouse model of septic shock.2?JTE-607 also showed inhibitory activity against acute myelogenous leukemia cell lines.3,4?Recently, the mechanism of action of JTE-607 (a pro-drug, with the active species being the free acid) has been found to be inhibition of pre-messenger RNA endonuclease Cleavage and Polyadenylation Specificity Factor 3 (CPSF3).5,6?This prevents release of newly synthesized mRNA’s resulting in read-through transcription and the formation of DNA-RNA hybrid R-loop structures. Transcripts down-regulated by JTE-607 were related to DNA damage-based phenotype.
Uses
JTE 607 Dihydrochloride is a cytokine release inhibitor.
Definition
ChEBI: JTE-607 dihydrochloride is the dihydrochloride salt of JTE-607. It is a cytokine inhibitor which suppresses the production of proinflammatory cytokines such as interleukin (IL-1beta), IL-6, IL-8, granulocyte macrophage colony stimulating factor (GM-CSF), and tumor necrosis factor (TNF-alpha). It acts as a pro-drug which is cleaved by carboxylesterase 1 (CES1) to its active free acid form, which then binds to cleavage and polyadenylation specificity factor 3 (CPSF3). It has a role as an anti-inflammatory agent, an antineoplastic agent, an apoptosis inducer, a prodrug, a cardioprotective agent and a CPSF3 inhibitor. It contains a JTE-607(2+).
in vivo
JTE-607 (0.3-10 mg/kg, i.v.) shows dose dependent inhibition of mortality after LPS challenge in C. parvum sensitized mice in accordance with a decrease of plasma TNF-α[1].
| Animal Model: | Male C57BL/6 mice (5 to 6 weeks old) are sensitized by injecting Corynebacterium parvum[1] |
| Dosage: | 0.3, 1, 3, 10 mg/kg |
| Administration: | Administered intravenously 10 min before the LPS challenge. |
| Result: | Showed dose dependent inhibition of the mortality at 0.3 to 10 mg/kg and significant effect at 3 and 10 mg/kg. |
IC 50
IL-10; IL-6; IL-8
storage
Desiccate at RT
References
[1] M KAKUTANI. JTE-607, a novel inflammatory cytokine synthesis inhibitor without immunosuppression, protects from endotoxin shock in mice.[J]. Inflammation Research, 1999, 48 8: 461-468. DOI:10.1007/s000110050487
[2] HIROYUKI IWAMURA K W Motohide Sato. Comparative study of glucocorticoids, cyclosporine A, and JTE-607 [(-)-Ethyl-N[3,5-dichloro-2-hydroxy-4-[2-(4-methylpiperazin-1-yl)ethoxy]benzoyl]-L-phenylalaninate dihydrochloride] in a mouse septic shock model.[J]. ACS Applied Electronic Materials, 2004: 1256-1263. DOI:10.1124/jpet.104.072421
[3] NAOFUMI UESATO . JTE-607, a multiple cytokine production inhibitor, ameliorates disease in a SCID mouse xenograft acute myeloid leukemia model[J]. Experimental hematology, 2006, 34 10: Pages 1385-1392. DOI:10.1016/j.exphem.2006.05.016
[4] NOBUYUKI TAJIMA. JTE-607, a multiple cytokine production inhibitor, induces apoptosis accompanied by an increase in p21waf1/cip1 in acute myelogenous leukemia cells[J]. Cancer Science, 2010, 101 3: 774-781. DOI:10.1111/j.1349-7006.2009.01446.x
[5] JUNYA KAKEGAWA. JTE-607, a multiple cytokine production inhibitor, targets CPSF3 and inhibits pre-mRNA processing[J]. Biochemical and biophysical research communications, 2019, 518 1: Pages 32-37. DOI:10.1016/j.bbrc.2019.08.004
[6] NATHAN T. ROSS. CPSF3-dependent pre-mRNA processing as a druggable node in AML and Ewing’s sarcoma[J]. Nature chemical biology, 2019, 16 1: 50-59. DOI:10.1038/s41589-019-0424-1
JTE-607 dihydrochloride Preparation Products And Raw materials
Raw materials
Preparation Products
JTE-607 dihydrochloride Suppliers
- Tel
- 020-39119399 18927568969
- Fax
- 020-39119999
- isunpharm@qq.com
- Country
- China
- ProdList
- 4720
- Advantage
- 55
- Tel
- 021-52996696，15000506266 15000506266
- Fax
- +86-21-52996696
- Country
- China
- ProdList
- 4795
- Advantage
- 55
- Tel
- 021-65675885 18964387627
- Fax
- 021-65675885
- info@efebio.com
- Country
- China
- ProdList
- 9803
- Advantage
- 58
- Tel
- 021-61312847; 18021002903
- Fax
- QQ:3008007432
- 3008007409@qq.com
- Country
- China
- ProdList
- 71826
- Advantage
- 60
- Tel
- 177-54423994 17754423994
- Fax
- QQ:2853530913
- 2853530910@QQ.com
- Country
- China
- ProdList
- 8000
- Advantage
- 62
- Tel
- 021-31433387 15618786686
- Fax
- QQ:1369748377
- sales@rechemscience.com
- Country
- China
- ProdList
- 2968
- Advantage
- 58
- Tel
- 021-QQ：65489617 15618227136
- Fax
- 21-5161 9052
- Sales@ATKchemical.com
- Country
- China
- ProdList
- 9503
- Advantage
- 58
- Tel
- 400-9205774
- sales@glpbio.cn
- Country
- China
- ProdList
- 6777
- Advantage
- 58
- Tel
- +1-781-999-5354; +17819995354
- marketing@targetmol.com
- Country
- United States
- ProdList
- 32470
- Advantage
- 58
- Tel
- 0512-0512-13601744364 13601744364
- chemsharker@126.com
- Country
- China
- ProdList
- 1073
- Advantage
- 58